Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise
Abstract With the increasing number of therapeutic strategies tested in humans to reduce the size of the latent reservoir, the development of a robust, precise and clinical trial scalable assay that measures the frequency of infected cells carrying inducible replication-competent HIV is urgently nee...
Main Authors: | Johann Plantin, Marta Massanella, Nicolas Chomont |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Retrovirology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12977-017-0385-y |
Similar Items
-
Conference highlights of the 5<sup>th </sup>international workshop on HIV persistence during therapy, 6-9 December 2011, St. Maartin, West Indies
by: Stevenson Mario, et al.
Published: (2012-03-01) -
HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
by: Deanna A. Kulpa, et al.
Published: (2015-04-01) -
Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8–11 December 2015, Miami, Florida, USA
by: David M. Margolis, et al.
Published: (2016-01-01) -
HIV reservoir in HIV patients
by: E. I. Veselova, et al.
Published: (2019-05-01) -
Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12–15 December 2017, Miami, FL, USA
by: Christina K. Psomas, et al.
Published: (2018-04-01)